Table 4.
Prevalence of safety issues for top 20 products advertised direct to consumers, 2009
| Drug | Safety warninga |
| Lipitor | Subject to recall; other safety notification |
| Ablify | Black box warning; subject to recall |
| Advair Diskus | Black box warning |
| Cymbalta | Black box warning |
| Cialis | Other safety notification |
| Lyrica | None |
| Plavix | Black box warning; subject to recall; other safety notification |
| Symbicort | Black box warning; other safety notification |
| Ambien CR | Other safety notification |
| Crestor | Other safety notification |
| Viagra | Other safety notification |
| Pristiq | Black box warning; other safety notification |
| Flomax | Other safety notification |
| Chantix | Black box warning |
| Yaz | Black box warning; other safety notification |
| Enbrel | Black box warning; subject to recall; other safety notification |
| Celebrex | Black box warning |
| Boniva | Other safety notification |
| Spiriva | Subject to recall |
| Caduet | None |
a “Other safety warnings” include voluntary recalls, counterfeit warnings, warnings on contraindications, warnings about combining with other drugs, and other US Food and Drug Administration-issued alerts.